We are independent & ad-supported. We may earn a commission for purchases made through our links.
Advertiser Disclosure
Our website is an independent, advertising-supported platform. We provide our content free of charge to our readers, and to keep it that way, we rely on revenue generated through advertisements and affiliate partnerships. This means that when you click on certain links on our site and make a purchase, we may earn a commission. Learn more.
How We Make Money
We sustain our operations through affiliate commissions and advertising. If you click on an affiliate link and make a purchase, we may receive a commission from the merchant at no additional cost to you. We also display advertisements on our website, which help generate revenue to support our work and keep our content free for readers. Our editorial team operates independently of our advertising and affiliate partnerships to ensure that our content remains unbiased and focused on providing you with the best information and recommendations based on thorough research and honest evaluations. To remain transparent, we’ve provided a list of our current affiliate partners here.

What is Platelet Aggregation?

By Cathy Crenshaw Doheny
Updated Mar 03, 2024
Our promise to you
The Health Board is dedicated to creating trustworthy, high-quality content that always prioritizes transparency, integrity, and inclusivity above all else. Our ensure that our content creation and review process includes rigorous fact-checking, evidence-based, and continual updates to ensure accuracy and reliability.

Our Promise to you

Founded in 2002, our company has been a trusted resource for readers seeking informative and engaging content. Our dedication to quality remains unwavering—and will never change. We follow a strict editorial policy, ensuring that our content is authored by highly qualified professionals and edited by subject matter experts. This guarantees that everything we publish is objective, accurate, and trustworthy.

Over the years, we've refined our approach to cover a wide range of topics, providing readers with reliable and practical advice to enhance their knowledge and skills. That's why millions of readers turn to us each year. Join us in celebrating the joy of learning, guided by standards you can trust.

Editorial Standards

At The Health Board, we are committed to creating content that you can trust. Our editorial process is designed to ensure that every piece of content we publish is accurate, reliable, and informative.

Our team of experienced writers and editors follows a strict set of guidelines to ensure the highest quality content. We conduct thorough research, fact-check all information, and rely on credible sources to back up our claims. Our content is reviewed by subject-matter experts to ensure accuracy and clarity.

We believe in transparency and maintain editorial independence from our advertisers. Our team does not receive direct compensation from advertisers, allowing us to create unbiased content that prioritizes your interests.

Platelet aggregation is the clustering together of thrombocytes, which are the small, cell-like structures made in the bone marrow that help prevent bleeding. This clumping can occur in response to many different agents, including the nucleotide adenosine diphosphate (ADP), and the proteins thrombin and collagen. Platelet aggregation is a crucial step in the process of clot formation, which stops bleeding.

A platelet aggregation test can be performed to determine how well platelets are sticking together. The test measures this by using a platelet antagonist to initiate clumping in the patient's blood sample. The most common platelet antagonists are ADP, thrombin, and ristocetin. After the antagonist is added to the blood sample, a special machine called an aggregometer measures the turbidity, or cloudiness, in the sample. The aggregometer records how quickly the platelets clump together by measuring the increased light and clarity in the fluid.

A physician may order the test if the results of a patient's complete blood count (CBC) indicates thrombocytopenia, which is a lower than normal level of platelets. The test may also be ordered if the patient has a family member that has been diagnosed with a bleeding disorder involving platelet dysfunction, or if he or she exhibits signs or symptoms of a bleeding disorder. These may include frequent nosebleeds, bleeding gums and easy bruising. Testing can help determine if these symptoms are due to a genetic problem, a different blood disorder, or if they are a side effect of a medication.

A decrease in platelet aggregation may suggest either a congenital disorder that has been present since birth, or an acquired one. Examples of congenital disorders that can result in decreased aggregation include Von Willebrand's disease, which is a lack of Von Willebrand factor or ristocetin co-factor in the blood, and Bernard-Soulier syndrome, a rare disease in which platelets cannot respond to Von Willebrand factor. Storage pool disease, a group of disorders that are characterized by defects in the materials that trigger aggregation, may also be detected using a platelet aggregation test.

Acquired conditions that may cause abnormal test results include autoimmune disorders that create antibodies against platelets, such as AIDS. Myeloproliferative diseases that cause the bone marrow to produce too many red blood cells, white blood cells and platelets, may also cause problems with the ability of platelets of aggregate. Storage pool disease can be an acquired cause of platelet aggregation in certain situations, especially in response to cardiopulmonary bypass — a procedure that temporarily takes control of heart and lung function during surgery — or vasculitis, an inflammation of the blood vessels.

The Health Board is dedicated to providing accurate and trustworthy information. We carefully select reputable sources and employ a rigorous fact-checking process to maintain the highest standards. To learn more about our commitment to accuracy, read our editorial process.
Discussion Comments
By pharmchick78 — On Aug 06, 2010

@StreamFinder -- You're right, a platelet aggregation assay, a platelet function assay, and a platelet aggregation study are all the same thing.

They are all intended to determine how well the platelets are functioning, and are all performed in generally the same way.

Although there are different methods for performing the tests, in the end, they all do the same thing.

By StreamFinder — On Aug 06, 2010

Is a platelet aggregation assay the same thing as a platelet function analysis?

My sister is going in to get a platelet function analysis on Monday, and we're trying to find out as much information as we can beforehand.

Thanks!

By rallenwriter — On Aug 06, 2010

In some cases, doctors can use platelet activating factors as the platelet antagonist.

Platelet activating factors (PAFs) occur naturally in the body, but some kinds can be synthetically manufactured for use in platelet aggregation studies.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.

The Health Board, in your inbox

Our latest articles, guides, and more, delivered daily.